课题基金 / 基金详情

Role of advanced glycation end-product in the development and progression of diabetic nephropathy.

Role of advanced glycation end-product in the development and progression of diabetic nephropathy.
晚期糖基化终产物在糖尿病肾病发生和进展中的作用。
批准号:
07671252
负责人:
MAKINO Hirofumi
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

MAKINO Hirofumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In diabetic state, glycation reaction of the proteins (Maillard reaction) undergoes and advanced glycation endproduct (AGE) accumulates in varous tissues. AGEs bind to the their receptors on the macrophages, and are known to induce the production of cytokines and nitric oxide (NO). Extracellular matrix with AGE modification is resistant to the proteolytic degradation. To explore the role of AGEs in the progression of the diabetic nephropathy, immunohistochemical studies of AGE and extracellular matrix components were performed in the kidney biopsy specimens of diabetic nephropathy patients, streptozotocin-induced diabetic rat kidney, and OLETF rat. In the mesangial area and tubules, AGEs were accumulated in the diabetic kidney. Especially in the nodular lesions of the diabetic kidneys, AGE were noted. By ultra-high resolution scanning electron microscopy showed enlarged meshwork of mesangial matrix of nodular lesions. These results indicated that AGEs accumulated with the progression of the diabetic nephropathy. AGEs may bind to the receptor on the mesangial cells and thus stimulate the production and inhibit the proteolytic degradations. AGEs may play a pivotal role in the alterations of the structual architecture of the extracellular matrix and glomerulosclerosis of the diabetic nephropathy.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Sugimoto H et al.: "Increased gene expression of insulin like growth factor-1 receptor in experimental diabetic rat glomeruli" Nephron. 72. 648-653 (1996)
Sugimoto H 等人:“实验性糖尿病大鼠肾小球中胰岛素样生长因子 1 受体的基因表达增加”肾单位。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Makino H et al: "Ultrastructure of nononzymatically glycated mesangial matrix in diabetic nephropathy" Kidney International. 48. 517-526 (1995)
Makino H 等人:“糖尿病肾病中非酶糖化系膜基质的超微结构”肾脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
植野博史: "糖尿病性腎症における細胞外基質異常とそのメカニズム," Therapeutic research,. 16. 2627-2631 (1995)
Hiroshi Ueno:“糖尿病肾病的细胞外基质异常及其机制”,治疗研究,16。2627-2631(1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Nuclear receptors as therapeutic targets for diabeticnephropathy.
    • 批准号:
      21249053
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.12万
    • 财政年份:
      2009
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    New therapeutic approach to diabetic nephropathy by modulating mitochondrial function
    • 批准号:
      18390249
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.0万
    • 财政年份:
      2006
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    Reactive oxygen species and diabetic nephropathy
    • 批准号:
      14370319
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.82万
    • 财政年份:
      2002
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    Molecular mechanism of glomerular hyperfiltration in diabetic nephropathy revealed by gene expression profiling.
    • 批准号:
      11470218
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.56万
    • 财政年份:
      1999
    • 负责人:
      MAKINO Hirofumi
    • 依托单位:
    国内基金
    海外基金
    BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
    • 批准号:
      82372724
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      何竑超
    • 依托单位:
    DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
    • 批准号:
      82370719
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      曹爱丽
    • 依托单位:
    Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
    • 批准号:
      81300605
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      唐琳
    • 依托单位:
    生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
    • 批准号:
      81101308
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      22.0万元
    • 批准年份:
      2011
    • 负责人:
      李海霞
    • 依托单位: